Drug Trial Radar · NCT04632940
Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD
Last checked: Nov 19, 2026Latest source record: Aug 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
73
Actual
Start
Mar 3, 2021
Primary completion
Jun 12, 2023
Study completion Dec 14, 2023
Sponsor
- Lead sponsor
- Kyntra BioIndustry
- Sponsor type
- Industry
- First posted
- Nov 17, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 6 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids administered every 2 weeks in ambulatory participants with Duchenne muscular dystrophy (DMD) (age 6 to \<12 years).
Conditions
- Duchenne Muscular Dystrophy
Interventions
PamrevlumabDrug
Pamrevlumab will be administered per dose and schedule specified in the arm description.
PlaceboDrug
Placebo will be administered per schedule specified in the arm description.
CorticosteroidsDrug
Systemic deflazacort or equivalent potency of corticosteroids administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in North Star Ambulatory Assessment (NSAA) Total Score at Week 52Time frame: Baseline, Week 52
Locations
52 sites in 11 countries. Site status is shown where the registry gives one.
Arkansas Children's Hospital
Little Rock, Arkansas
Children's Hospital Los Angeles
Los Angeles, California
University of California Davis Children's Hospital
Sacramento, California
University of California San Diego Health
San Diego, California
Children's Hospital Colorado
Aurora, Colorado
University of Florida Health Shands Hospital
Gainesville, Florida
Rare Disease Research - Tampa
Tampa, Florida
Rare Disease Research Center
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
University of Iowa Hospitals and Clinics
Iowa City, Iowa
University of Kansas Medical Center Research Institute
Fairway, Kansas
Kennedy Krieger Institute
Baltimore, Maryland
University of Massachusetts Memorial Center
Worcester, Massachusetts
C.S. Mott Children's Hospital
Ann Arbor, Michigan
Spectrum Health Hospitals Helen DeVos Children's Hospital
Grand Rapids, Michigan
Washington University School of Medicine in St. Louis
St Louis, Missouri
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Shriners Hospital for Children
Portland, Oregon
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
Texas Children's Hospital
Houston, Texas
University of Utah Health
Salt Lake City, Utah
University of Virginia Children's Hospital
Charlottesville, Virginia
Children's Hospital of The King's Daughters
Norfolk, Virginia
Seattle Children's Hospital
Seattle, Washington
Children's Wisconsin Corporate Center
Milwaukee, Wisconsin
Murdoch Children's Research Institute
Parkville, Victoria, Australia
Klinik Favoriten
Vienna, State of Vienna, Austria
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Flemish Brabant, Belgium
Centre Hospitalier Régional de la Citadelle
Liège, Liege, Belgium
Universitair Ziekenhuis Gent
Ghent, Oost-Vlaanderen, Belgium
London Health Sciences Centre
London, Ontario, Canada
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, China
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The 1st Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Xiangya Hospital Central South University
Changsha, Hunan, China
West China Second University Hospital, Sichuan University
Chengdu, Sichuan, China
Centre Hospitalier Universitaire Nantes - Hôtel Dieu
Nantes, France
Association Institut de Myologie
Paris, France
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.